Company Filing History:

10 out of 1,929

Ajinomoto Co., Ltd.

Years Active: 2007-2017

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9655879 - Heteroarylcarboxylic acid ester derivative (2017-05-23),

2. 9227949 - Heteroarylcarboxylic acid ester derivative (2016-01-05),

3. 9024044 - Heteroarylcarboxylic acid ester derivative (2015-05-05),

4. 8546610 - Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of the derivatives (2013-10-01),

5. 8309561 - Phenylalanine derivatives (2012-11-13),

6. 8268844 - Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-l-phenylalanine hydrochloride, production method thereof and use thereof (2012-09-18),

7. 8058432 - Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of derivatives (2011-11-15),

8. 7902179 - Heterocyclic compounds (2011-03-08),

9. 7842700 - Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-L-phenylalanine hydrochloride, production method thereof and use thereof (2010-11-30),

10. 7345049 - Phenylalanine derivatives (2008-03-18),

11. 7279484 - Heterocyclic compounds (2007-10-09),

Title: The Innovative Journey of Tatsuhiro Yamada

Introduction

Tatsuhiro Yamada, an esteemed inventor based in Kawasaki, Japan, has made significant contributions to the field of pharmaceutical inventions. With a remarkable portfolio of 11 patents, Yamada continues to advance the understanding and treatment of diabetes through his innovative compounds.

Latest Patents

Among his recent achievements, Tatsuhiro Yamada has filed patents for heteroarylcarboxylic acid ester derivatives. These compounds, represented by specific formulas, are highlighted for their utility as hyperglycemic inhibitors. They exhibit serine protease inhibitory action, positioning them as potential prophylactic and therapeutic drugs for diabetes. The dual focus on both prevention and treatment showcases Yamada's commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Tatsuhiro Yamada has collaborated with prominent companies in the pharmaceutical industry. Notable among these are Ajinomoto Co., Ltd. and Ea Pharma Co., Ltd. His work has not only fostered innovation within these organizations but has also contributed significantly to the broader field of medicinal chemistry.

Collaborations

Yamada's success is further reflected in his collaborations with notable coworkers, including Tadakiyo Nakagawa and Tamotsu Suzuki. These partnerships have enriched his research endeavors, facilitating a blend of ideas and expertise that has propelled his inventions forward.

Conclusion

In conclusion, Tatsuhiro Yamada exemplifies the spirit of innovation within the pharmaceutical landscape. His dedication to creating compounds that address important medical needs underscores the impact that skilled inventors have on society. With continued research and development, the future looks promising for his contributions, particularly in the fight against diabetes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

2 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.